Literature DB >> 30286846

Validity and Reliability of the Spanish Version of the Montreal Cognitive Assessment (MoCA) for the Detection of Cognitive Impairment in Mexico.

Sara G Aguilar-Navarro1, Alberto J Mimenza-Alvarado2, Alberto A Palacios-García3, Alejandra Samudio-Cruz4, Lidia A Gutiérrez-Gutiérrez3, José A Ávila-Funes5.   

Abstract

OBJECTIVE: To establish the validity and reliability of the Montreal Cognitive Assessment in Spanish (MoCA-S) to identify mild cognitive impairment (MCI) and dementia in the Mexican elderly population.
MATERIAL AND METHODS: 168 participants from a memory clinic in Mexico City were enrolled and divided into 3 groups: 59 cognitively healthy (CHG), 52 with mild cognitive impairment (MCI) (DSM-5 criteria) and 57 with dementia (NINCDS-ADRDA criteria). The MoCA-S and Mini-Mental State Evaluation (MMSE) were applied at baseline and during the last months to establish intra-observer reliability. ROC curves and a multinomial regression model were constructed to evaluate the effect of age and education on MoCA-S performance.
RESULTS: The mean age of the participants was 76±8.1 years and the education rate was 10.7±5.2. The MoCA-S scores by group were: CHG, 27.3±1.9; MCI, 22.9±2.9; and dementia, 13.7±4.9 (p<0.001). The reliability of the MoCA-S was 0.89 and the intraclass correlation coefficient was 0.955. Sensitivity was 80% and specificity was 75%, with a cut-off point of 26 points for MCI (area under the curve, 0.886; p<0.001). For the dementia group, the sensitivity was 98% and specificity was 93%, with a cut-off point of 24points (area under the curve, 0.998; p<0.001). The multinomial regression showed no association with education and age for both the MCI and dementia groups.
CONCLUSIONS: The MoCA-S is a valid and reliable instrument for MCI and dementia screening in the Mexican population, even after adjusting for age and education.
Copyright © 2017 Asociación Colombiana de Psiquiatría. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adultos mayores mexicanos; Demencia; Dementia; Deterioro cognitivo leve; Mexican elderly population; Mild cognitive impairment; Montreal Cognitive Assessment in Spanish; Montreal Cognitive Assessment-español

Mesh:

Year:  2017        PMID: 30286846     DOI: 10.1016/j.rcp.2017.05.003

Source DB:  PubMed          Journal:  Rev Colomb Psiquiatr (Engl Ed)        ISSN: 2530-3120


  14 in total

1.  Impact of Obstructive Sleep Apnea (OSA) in COVID-19 Survivors, Symptoms Changes Between 4-Months and 1 Year After the COVID-19 Infection.

Authors:  Gonzalo Labarca; Mario Henríquez-Beltrán; Liliana Lamperti; Estefania Nova-Lamperti; Sergio Sanhueza; Camilo Cabrera; Romina Quiroga; Barbara Antilef; Valeska Ormazábal; Felipe Zúñiga; Daniela Castillo; Gloria Horta; Daniel Enos; Jaime Lastra; Jessica Gonzalez; Adriano Targa; Ferran Barbe
Journal:  Front Med (Lausanne)       Date:  2022-06-14

2.  Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population.

Authors:  Sebastian Bello-Lepe; María Francisca Alonso-Sánchez; Alonso Ortega; Marcelo Gaete; Marcela Veliz; Juan Lira; Claudia Paz Perez Salas
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2020-10-14

3.  Comparison of Montreal Cognitive Assessment in Korean Version for Predicting Mild Cognitive Assessment in 65-Year and Over Individuals.

Authors:  Chiang-Soon Song; Hye-Sun Lee; Byung-Yoon Chun
Journal:  Occup Ther Int       Date:  2022-04-19       Impact factor: 1.565

4.  Breast Arterial Calcification Is Not Associated with Mild Cognitive Impairment or Incident All-Cause Dementia Among Postmenopausal Women: The MINERVA Study.

Authors:  Carlos Iribarren; Malini Chandra; Sabee Molloi; Gabriela Sanchez; Fatemeh Azamian-Bidgoli; Hyo-Min Cho; Huanjun Ding; Kristine Yaffe
Journal:  J Womens Health (Larchmt)       Date:  2020-12-07       Impact factor: 3.017

5.  Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment.

Authors:  Bian-Rong Wang; Hui-Fen Zheng; Chang Xu; Yi Sun; Ying-Dong Zhang; Jian-Quan Shi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-13       Impact factor: 2.570

6.  Association between ApoE ε4 Carrier Status and Cardiovascular Risk Factors on Mild Cognitive Impairment among Mexican Older Adults.

Authors:  Sara G Aguilar-Navarro; Itzel I Gonzalez-Aparicio; José Alberto Avila-Funes; Teresa Juárez-Cedillo; Teresa Tusié-Luna; Alberto Jose Mimenza-Alvarado
Journal:  Brain Sci       Date:  2021-01-07

7.  Planning deficits in Huntington's disease: A brain structural correlation by voxel-based morphometry.

Authors:  Jesus Calderon-Villalon; Gabriel Ramirez-Garcia; Juan Fernandez-Ruiz; Fernanda Sangri-Gil; Aurelio Campos-Romo; Victor Galvez
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

8.  Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas Mexico.

Authors:  Pablo F Belaunzarán-Zamudio; Ana M Ortega-Villa; Alberto J Mimenza-Alvarado; Paola Del Carmen Guerra-De-Blas; Sara G Aguilar-Navarro; Jesús Sepúlveda-Delgado; Sally Hunsberger; Raydel Valdés Salgado; José Ramos-Castañeda; Héctor Armando Rincón León; Paul Rodríguez de La Rosa; José Gabriel Nájera Cancino; John Beigel; Sandra Caballero Sosa; Emilia Ruiz Hernández; John H Powers; Guillermo M Ruiz-Palacios; Clifford Lane
Journal:  Front Neurol       Date:  2021-03-22       Impact factor: 4.003

9.  A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.

Authors:  Ana M Rodríguez-Salgado; Jorge J Llibre-Guerra; Elena Tsoy; Ana Ibis Peñalver-Guia; Giosmany Bringas; Sabrina J Erlhoff; Joel H Kramer; Isabel Elaine Allen; Victor Valcour; Bruce L Miller; Juan J Llibre-Rodríguez; Katherine L Possin
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Discounting, Cognitive Inflexibility, and Antisocial Traits as Predictors of Adolescent Drug Involvement.

Authors:  Laura Hernández; Diana Mejía; Laurent Avila-Chauvet
Journal:  Front Psychol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.